Advancing Prostate Cancer Care: Integrating Guideline Updates and Patient Preferences for Optimal ADT Management of Advanced Prostate Cancer
Tanya Dorff, MD
Rana McKay, MD
Innovations in Oncology Learning Center From Guidelines to Practice: Gynecologic Cancer
Susana Campos, MD, MPH
Nicoletta Colombo, MD
Ritu Salani, MD, MBA
Emerging targeted therapy combination strategies in genitourinary malignancies
Ignacio Duran, MD
Emerging immunotherapy combination strategies in genitourinary malignancies
Sandy Srinivas, MD
Clinical Evidence Behind Emerging Targeted Therapy Strategies Across Gynecologic Malignances
Guideline-recommended second-line treatment following an immune checkpoint inhibitor in renal cell carcinoma
Wenxin Xu, MD
Insights from global key opinion leaders on optimizing patient care in genitourinary malignancies
Emerging and Practice-Changing Directions in Gynecologic Malignances Involving Combination Therapies With Immune Checkpoint Inhibitors
Guideline Updates for ADT: Best Practices for Treating Advanced Prostate Cancer
Implementing Guideline-Concordant Care Into a Targeted Therapy Approach for Patients With Platinum-Resistant Ovarian Cancer
Insights From Global Key Opinion Leaders on Optimizing Patient Care in Gynecologic Malignances
Best Practices in Shared Decision-Making: Discussing ADT Regimens in mHSPC With Your Patient
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Incorporation of guideline-concordant care for first-line treatment of a patient with metastatic urothelial carcinoma
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.